Uvazest zoom


Full Screen

Uvazest contains Dienogest, which decreases Estrogen level by acting both on the peripheral and central pathway of Estrogen production with Anti-inflammatory, anti-proliferative and Anti-angiogenic properties. Endorsed by multiple gynaecology guidelines which makes it one of the trusted treatment option among medical fraternity. Uvazest ensures 33% spontaneous pregnancy rate in previously infertile patients with Endometriosis.



  • In pelvic pain associated with Endometriosis
  • Secondary dysmenorrhea
  • Ovarian Chocolate Cyst
  • Adenomyosis Pre & Post-operative treatment and Extra-genital Endometriosis


Each Tablet Contains 2mg Dienogest.

Direction of use

Dosage: One tablet once daily minimum for 6 months and can be taken any day of the cycle or as advised by your doctor.